RADNOR, Pa. (BUSINESS WIRE) Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced the grant of inducement awards to four new employees. The Compensation Committee of the Board of Directors of Marinu.
Marinus Pharmaceuticals, Inc. , a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced the grant of inducement awards to four new.
Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Marinus Pharmaceuticals, Inc. , a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced the grant of inducement awards to four new employees. The Compensation Committee of the Board.
Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) Receives Consensus Rating of "Moderate Buy" from Analysts themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Financial Review: Marinus Pharmaceuticals (NASDAQ:MRNS) and Trevi Therapeutics (NASDAQ:TRVI) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Marinus Pharmaceuticals (NASDAQ:MRNS) & Trevi Therapeutics (NASDAQ:TRVI) Financial Survey themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
StockNews.com upgraded shares of Marinus Pharmaceuticals (NASDAQ:MRNS – Free Report) from a sell rating to a hold rating in a research report report published on Saturday morning. Several other research firms also recently commented on MRNS. HC Wainwright reissued a buy rating and issued a $27.00 target price on shares of Marinus Pharmaceuticals in a […]
Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) Receives Consensus Recommendation of "Moderate Buy" from Analysts theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Research Analysts’ upgrades for Saturday, January 27th: Amgen (NASDAQ:AMGN) was upgraded by analysts at StockNews.com from a buy rating to a strong-buy rating. Morningstar (NASDAQ:MORN) was upgraded by analysts at StockNews.com from a hold rating to a buy rating. Marinus Pharmaceuticals (NASDAQ:MRNS) was upgraded by analysts at StockNews.com from a sell rating to a hold […]